These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 6715121

  • 1. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J, Toncsev H, Sréter L, Cornides A, Kiss A.
    Int J Tissue React; 1984; 6(1):75-80. PubMed ID: 6715121
    [Abstract] [Full Text] [Related]

  • 2. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J, Toncsev H, Fehér E, Kiss A, Vasady A.
    Int J Tissue React; 1981 Mar; 3(1):31-7. PubMed ID: 7287055
    [Abstract] [Full Text] [Related]

  • 3. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Mar; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Mar; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 5. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Mar; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 6. Glycohydrolases and lysosomal stability in adjuvant induced arthritis.
    Arumugham R, Bose SM.
    Ital J Biochem; 1980 Mar; 29(1):27-40. PubMed ID: 7380646
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical and experimental studies on changes in lysosomal enzyme activity in fatty livers (author's transl)].
    Yamada J.
    Hokkaido Igaku Zasshi; 1978 May; 53(3):191-204. PubMed ID: 711125
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984 May; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986 May; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 May; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I, Dalmi L, Sári B.
    Acta Physiol Hung; 1984 May; 64(3-4):471-4. PubMed ID: 6532130
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antishock effect of gabexate mesilate (FOY).
    Oda T, Miyawaki T, Sameshima T, Miyao J, Arai Y, Yoshimine K, Yoshimura N.
    Prog Clin Biol Res; 1983 May; 111():293-307. PubMed ID: 6408649
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.